Results 31 to 40 of about 310,928 (240)
Mechanical circulatory support for destination therapy. [PDF]
Patients with chronic heart failure who are not eligible for heart transplant and whose life expectancy depends mainly on the heart disease may benefit from mechanical circulatory support.
Hullin, R., Tozzi, P.
core +1 more source
BackgroundRepeat hospitalizations, complications, and psychosocial burdens are common in patients with left ventricular assist devices (LVAD). Specialist palliative care (sPC) involvement supports patients during decision-making until end-of-life. In the
Theresa Tenge+18 more
doaj +1 more source
Heart Rate Variability: A possible machine learning biomarker for mechanical circulatory device complications and heart recovery [PDF]
Cardiovascular disease continues to be the number one cause of death in the United States, with heart failure patients expected to increase to \u3e8 million by 2030.
Aras, Shravan+2 more
core +1 more source
This paper presents the results of experimental performance of an innovative left ventricular assist device working on a specially designed test stand. The introduced invention is mainly applied for supporting the heart in patients with end-stage heart ...
Krzysztof Tesch+3 more
doaj +1 more source
Heart Failure Anticoagulation Teach-Back Education and Readmissions [PDF]
: Heart failure affects millions of Americans each year. Treatment of advanced heart failure with reduced ejection fraction and left ventricular failure is sometimes treated with implantation of a left-ventricular assist device.
core
Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices [PDF]
Background: The rising number of patients with a left ventricular assist device (LVAD) require care management to successfully transition home after implantation. These patients and their families need to manage their heart failure, and the complexities
Hirschman, Karen+3 more
core +1 more source
This paper presents the results of a study on the effect of vascular lumen reduction on the performance of an innovative implantable LVAD (left ventricular assist device).
Ryszard Jasinski+3 more
doaj +1 more source
Measurement of a single marker of coagulation may not provide a complete picture of hemostasis activation and fibrinolysis in patients with chronic cardiovascular diseases. We assessed retrospective orders of a panel which included prothrombin fragment 1.
Maureen J. Miller MD, MPH+3 more
doaj +1 more source
This paper presents the operation of an innovative left ventricular assist device under various resistances and operating frequencies. The operating principle of the device is based on pulsatile blood flow, which is forced by a suction–discharge device ...
Ryszard Jasinski+3 more
doaj +1 more source
Pulsatile Mechanical Heart Assist Device
In this paper is described an innovative, easy to reuse heart assist device implying low production and maintenance costs, which needs minimally invasive techniques for the connection to the arterial system and that assists the failing heart according to the counterpulsation principle as an eligible solution for developing countries but also in case of
Pleşoianu, F.A.+3 more
openaire +3 more sources